← SynDRA
DEFLAZACORT
SynDRA canonical compound SYN0023631 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | glucocorticoid receptor agonist |
|---|
| Indication | joint inflammation |
|---|
| Disease area | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- NR3C1 AGONIST
- NR3C1 MODULATOR
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Inflammatory Agents
- Immunologic Factors
- Immunosuppressive Agents
ATC classes
- H02A · CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Cross-references
Synonyms
- azacort
- azacortinol
- calcort
- dezacor
- dezacort
- flantadin
- lantadin
- oxazacort
- Azacortinol
- DL-458IT
- L-5458
- MDL-458
- MDL458
- Calcort
- Emflaza
- Zamene
- C25H33NO6
- Deflazacort (Calcort)
- Deflazacortum [INN-Latin]
- EINECS 238-483-7
- Deflan (TN)
- AC1L1BQ2
- Deflazacort [USAN:BAN:INN]
- CTK8F9001
- MolPort-035-394-927
- Azacort
- Oxazacort
- Flantadin
- Cortax
- Deflan
- KR5YZ6AE4B
- Dezacor
- Lantadin
- 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10-trimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate
- Deflazacortum
- Decortil
- Deflanil
Reported adverse events
- Abdominal discomfort
- Acne
- Anxiety
- Back injury
- Back pain
- Chromaturia
- Cough
- Cushingoid
- Dizziness
- Dyspepsia
- Erythema
- Glucose urine present
Look up DEFLAZACORT in the interactive SynDRA portal →